The Mito Cocktail – What you need to know!
One of the front-line treatment approaches to a mitochondrial disease is to use a combination, unique to each patient based on symptoms and diagnosis, of vitamins and supplements such as Coenzyme Q10, B-vitamins, L-Carnitine, Creatine, and Alpha Lipoic Acid.
Compounding pharmacists Saad Dinno and Ted Toufas from Acton Pharmacy will be discussing the ingredients which make up the mysterious “Mito Cocktail.”
Some talking points will include:
- What is a compounding pharmacist?
- How do ingredients in the Mito Cocktail differ from a compounding pharmacist than an over-the-counter source?
- What are the side effects of the vitamins & supplements used to support adults and children with mitochondrial disease?
- Which vitamins and supplements are most commonly included in a treatment regimen?
About The Speaker:
Ted Toufas, BS, PharmD, RPh
Ted Toufas BS, PharmD, RPh, Clinical Pharmacist and Pharmacist-in-Charge Compounding Lab at Acton Pharmacy, and Adjunct Assistant Professor, graduated in 2004 from WPI with a degree in Biochemistry, and in 2011 earned his Pharmacy Doctorate from Mass College of Pharmacy in Boston. He has worked in the compounding lab at Acton Pharmacy since 2005 as a technician, intern, and pharmacist.
Over the years, he has built close relationships with his patients and providers, working closely with them to develop dosage forms that meet individualized needs. He has worked with mitochondrial providers and patients, trying to match the best formulation for taste and dosage form for ease of use. In addition, he has developed formulations, training for staff, and protocols for the lab.
While he has been at Acton, the lab has received accreditation by the Pharmacy Compounding Accreditation Board (a voluntary national inspection), UCAP (another voluntary national inspection, geared for insurances), and high marks in a National Association of Boards of Pharmacy inspection (required for UCAP accreditation). He continues to strive for improvement through training and education, both in pharmacy compounding and regulations.
Saad Dinno, RPh
Saad Dinno, RPh, FIACP, FACA, has given lectures on mitochondrial disease across the country as well as in Australia. His staff works with patients and their providers on insurance coverage issues, compliance, taste, dosage form, counseling on the medications being dispensed, and other relevant Mito information and general questions.
He is a member of the Massachusetts Independent Pharmacy Association, Massachusetts Pharmacist Association, National Community Pharmacist Association, and International Academy of Compounding Pharmacists. He is the past president of the Massachusetts Independent Pharmacy Association and previously served on the Professional Compounding Centers of America (PCCA) Advisory Board.
Saad has received numerous awards, including being named the Margaret Bauman Outstanding Medical Professional for his work serving the autism community.
He was also named Massachusetts Innovative Pharmacist of the Year, PCCA Pharmacist of the Month, and received a Fellowship distinction from the International Academy of Compounding Pharmacists. Additionally, Saad serves on Emerson Hospital’s Care Transition Collaborative Committee, the Eliot Community Human Rights Committee, Cardinal Distribution East Advisory Board and the MitoAction Marcel Way Fund Committee. He received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Health Sciences.
Speaker: Ted Toufas & Saad Dinno
Listen Now: Click Here
View Slides: Click Here
Related Articles
PTC743 (Vatiquinone) for the Treatment of Mitochondrial Disease With Associated Epilepsy
Date: 11/06/2020Speaker: Matt Klein & Francesco Bibbiani
Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
Date: 07/25/2020Speaker: Camille Bedrosian & Bridget Reineking